SYNOPSIS Patients with chronic liver disease, yet without severe encephalopathy, were found to show evidence of increased brain utilization of glucose. The changes were abolished after an intravenous infusion of 15 g ornithine alpha oxoglutarate, given over a period of 15 minutes. The possible implications of these observations are discussed.
When ammonium salts were given intravenously to freely ventilating dogs to raise the blood ammonia to those levels found in hepatic encephalopathy, the glucose utilization of the brain was increased without similar increase in oxygen consumption. This rise in glucose utilization resulted in lactic acidosis and hyperventilation .
The earliest disturbance of brain metabolism in patients with liver disease was an increase in the cerebral utilization of glucose at a time when oxygen consumption was little changed. Cerebral blood flow initially was elevated . However, as the encephalopathy became more severe, oxygen and then glucose consumption of the brain, together with cerebral blood flow, decreased. These changes have been interpreted as showing evidence of anaerobic glycolysis (Alexander et al., 1965) .
Despite the fact that Fazekas et al. (1956) were unable to detect any correlation between the changes in cerebral oxygen consumption and the elevation of blood ammonia in their patients, of all possible aetiological factors concerned in the genesis of encephalopathy, ammonia still remains one of the most favoured (Zieve, 1966) . In the dog experiments referred to above administration of ornithine alpha oxoglutarate not only alleviated the rise in blood ammonia that occurred but also favourably affected the changes in brain metabolism . (Accepted 13 September 1974.) 
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The purpose of the present study was to determine in patients with hepatic disease whether ornithine alpha oxoglutarate infusion affected brain metabolism in any similar way, particular attention being paid to cerebral glucose utilization. Patients with chronic liver disease who exhibited only minimal neurological signs (grade 1 electroencephalogram (EEG) at most) were chosen, as it was felt that these were the most likely of all to have high cerebral glucose consumption rates. Brain oxygen and glucose consumption were studied in six such patients before and after the intravenous infusion of ornithine alpha oxoglutarate (OAKG) over a period of 15 minutes.
A further patient admitted in deep coma (grade 4 EEG) was also studied before and after four hours' infusion with 60 g ornithine alpha oxoglutarate.
METHODS
CEREBRAL BLOOD FLOW AND METABOLISM Cerebral blood flow was measured using radioactive krypton gas by a modification of the McHenry desaturation technique (McHenry, 1964) . Under 2% procaine local anaesthesia, small needles (21 gauge) with catheters attached were inserted in the jugular bulb as described by Gibbs et al. (1945) , and into the femoral artery. Once the needles and attached catheters were in position the patient breathed from a spirometer containing radioactive 85Krypton in air for 10 minutes. Then the patient breathed room air and timed samples were taken from both femoral artery and jugular bulb during the next 10 minutes group.bmj.com on April 8, 2017 -Published by http://jnnp.bmj.com/ Downloaded from group.bmj.com on April 8, 2017 -Published by http://jnnp.bmj.com/ Downloaded from for subsequent 85Krypton analysis. The conventional height over area formula was used to derive cerebral blood flow.
Samples were also taken from the artery and the jugular bulb for oxygen and glucose content so that consumption of oxygen and glucose by the brain could be calculated.
Arterial and venous samples for lactate levels were obtained from the six patients with mild encephalopathy.
Oxygen content was measured by the method of Linden et al. (1965) and glucose by a glucose oxidase method (Trinder, 1969) .
The pH and PCO2 were measured with appropriate radiometer electrodes. Lactic acid levels were measured by the method of Hohorst (1963) .
The aerobic index has been calculated as an index of the aerobic metabolism of glucose as suggested by Alexander et al. (1965) . CEREBRAL BLOOD FLOW A wide scatter in values from 38 ml/100 g/min to 79 ml/100 g/min was found. There was no overall change in cerebral blood flow as a result of OAKG therapy but individually some changes were fairly substantial (patient 1 and patient 4). Changes in PaCO2 do not appear to have been the reason for these flow changes (Table 1) .
CEREBRAL METABOLISM In most patients there was an increase in cerebral oxygen consumption. (1969) .
As expected, the values for brain oxygen consumption were higher than those for patients with severe neurological abnormality (Lunzer et al., 1974) .
The validity of calculating brain oxygen, glucose consumption, and lactic acid production depends on whether the venous blood concentration draining the organ is in equilibrium with the tissue concentration and that the arterial concentration is constant (Zierler, 1961) . Alexander et al. (1965) felt that so far as the brain was concerned equilibrium was quickly attained for both oxygen and glucose but not for lactate.
Oxygen and glucose consumption levels have been calculated ( The increase in glucose utilization and ultimate failure of the tricarboxylic acid cycle was attributed by Bessman and Bessman (1955) to the depletion of intracellular alpha oxoglutarate by excess ammonia. They postulated that glutamate and eventually glutamine would be formed; the rise in lactic acid could be explained as being secondary to the failure of the cycle.
On the other hand, it has been argued by McKhann and Tower (1961) that lactic acidosis in liver disease could result from the inhibition of decarboxylation of pyruvate to acetyl CoA by ammonia. Some further evidence to support this contention was cited by Klassen et al. (1969) who found increased muscle lactic acid production in patients and that this was related to blood ammonia elevation. Since fatty acid utilization was normal, these workers felt that the citric acid cycle was functioning normally from acetyl CoA onwards.
Ornithine alpha oxoglutarate administration causes a fall in the cerebral glucose utilization and an increase in oxygen consumption. It is known that ammonia can, in laboratory animals, provoke cerebral anaerobic glycolysis and that OAKG is able to lower blood ammonia in patients with liver failure (Michel et al., 1971 The fall in cerebral glucose utilization could then be explained by some form of negative feedback mechanism from the cycle.
We have previously suggested that CO2 production could be the important factor. It is known that elevated CO2 levels decrease (Xanalatos and James, 1972) and lowered CO2 levels increase glucose utilization by the brain (Alexander et al., 1965) .
It must be remembered also that ammonia is only one of many factors that can cause cerebral anaerobic glycolysis. Thus, the finding of anaerobic glycolysis in patients with hepatic encephalopathy together with its reversal by OAKG does not necessarily imply that ammonia is involved.
In patients with hepatic encephalopathy, the biochemical disturbance of anaerobic glycolysis can be at least partially reversed with alpha oxoglutarate administration but the mechanism by which these changes are effected remains in doubt. 
